# FDA 483 - InvaTech Pharma Solutions, LLC - May 13, 2026

Source: https://www.keypedia.com/records/483/invatech-pharma-solutions-llc/16a6ca1f-3bac-43c9-9521-0ccf5e0dd14c

> FDA 483 for InvaTech Pharma Solutions, LLC on May 13, 2026. Product: drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: InvaTech Pharma Solutions, LLC
- Inspection Date: 2026-05-13
- Product Type: drugs
- Office Name: FDA District Office — Parsippany, New Jersey
- Summary: An FDA inspection of InvaTech Pharma Solutions, LLC in East Brunswick, NJ, a drug manufacturer, revealed multiple significant deficiencies. These included inadequate sampling of high-risk components, failure to prevent objectionable microorganisms in non-sterile products, and issues with equipment design. Additionally, the firm lacked proper qualification of laboratory standards, failed to conduct annual visual inspections of retain samples, and exhibited poor material handling and storage practices.

## Related Documents

- [483 - 2017-04-04](https://www.keypedia.com/records/483/invatech-pharma-solutions-llc/318ba5c8-a85d-4ac6-80d8-fc7143b5e93d)
- [483 - 2017-12-28](https://www.keypedia.com/records/483/invatech-pharma-solutions-llc/e53ca456-2123-47f7-a239-c00aaed5661b)
- [483 - 2019-02-05](https://www.keypedia.com/records/483/invatech-pharma-solutions-llc/2690f600-078e-48b8-9c11-01e002f1066a)
- [483 - 2023-06-09](https://www.keypedia.com/records/483/invatech-pharma-solutions-llc/72351d09-9e17-4f73-a196-2f7193d5627c)

## Related Officers

- [Suchan Kim](https://www.keypedia.com/people/suchan-kim/1acf9a36-036f-48a8-a8a4-caa290830e37)
- [Alisha B. Patel](https://www.keypedia.com/people/alisha-b-patel/3c106dac-0e0d-41f2-9f7a-69982d4e6579)

Company: https://www.keypedia.com/companies/invatech-pharma-solutions-llc/a4957f07-dcf0-47ec-a41a-7effe7e4a8e3

Office: https://www.keypedia.com/offices/fda-district-office-parsippany-new-jersey/d0f9de06-c0ec-4c7a-bce9-c6c0496b7de7